Concerns from bench and insights from bedside: the puzzle of Roxadustat in cancer patients with chemotherapy-induced anemia. [PDF]
Chen L, Liao S, Jing D, Mao L, Tan J.
europepmc +1 more source
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study. [PDF]
Kattamis A +8 more
europepmc +1 more source
Codanin-1, defective in congenital dyserythropoietic anemia I (CDA-I), regulates erythroid differentiation. [PDF]
Bosques L +11 more
europepmc +1 more source
Mitochondrial iron transport via MFRN1 is required for erythroid cell cycle progression. [PDF]
Perfetto M +9 more
europepmc +1 more source
Translation of the Morphological Hallmarks of Dyserythropoiesis to Objective Morphometric Parameters by Imaging Flow Cytometry. [PDF]
Despoina Violidaki DV +4 more
europepmc +1 more source
Insights Into Terminal Erythropoiesis Influenced By Human Genetic Variation
Elizabeth A. Traxler
openalex +1 more source
A new framework for erythropoiesis-stimulating agent resistance based on body mass index-fat tissue index classification. [PDF]
Ito H, Mori T.
europepmc +1 more source
DDX41 resolves G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death. [PDF]
Bi H +17 more
europepmc +1 more source
Anemia and Iron Deficiency in Cardiac Surgery Patients: Prevalence, Implications, and Therapeutic Considerations. [PDF]
Frei I, Gogniat AL, Buser A, Bolliger D.
europepmc +1 more source
Erythroid activity modulates iron regulation in pathological erythropoiesis: A cross-sectional case-control study. [PDF]
Santhakumar S +6 more
europepmc +1 more source

